跳至主要内容
临床试验/NCT02238093
NCT02238093Unknown不适用

Cardiorenal Syndrome in End-Stage Kidney Disease

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
270
试验地点
1
主要终点
Heart Pathology Identification

研究概览

简要总结

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality.

The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • End-stage renal patients

排除标准

  • Cancer patients

结局指标

主要结局

Heart Pathology Identification

时间窗: One hour

Visual identification of heart pathology in ESRD patients using echocardiography by measuring the ejection fraction of the left-ventricle during the systolic and diastolic phases. Valvular pathology is measured by the size of the valve.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验